News | News By Subject | News by Disease News By Date | Search News

Vaccine News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Profectus BioSciences, Inc. Nabs $9.5 Million Government Grant     10/31/2014
Pfizer Wins FDA Accelerated Approval For Meningitis Vaccine     10/30/2014
ImevaX Secures EUR 7.5 Million In Series A Financing To Develop Highly Specific Vaccine Against Helicobacter Pylori Infections     10/28/2014
Novartis AG Sells Flu Vaccine Business For $275 Million To CSL Limited     10/28/2014
New Role Created At GlaxoSmithKline's Vaccines Unit     10/23/2014
NIH Begins Early Human Clinical Trial Of VSV Ebola Vaccine     10/23/2014
Successful Spin-Out of ImevaX Gmbh From The Technische Universität München (TUM) And Funding By The Federal Ministry Of Education And Research (BMBF) With EURO 5.9 Million     10/15/2014
Well-Capitalized VaxInnate Corporation Gets Another $6 Million For Its Bacteria-Based Flu Vaccines     10/3/2014
Soligenix Awarded National Institute of Allergy And Infectious Diseases (NIAID) Contract Valued Up To $24.7 Million     9/19/2014
PharmAthene, Inc. Awarded Contract Of Up To $28.1 Million To Develop Next Generation Thermostable Anthrax Vaccine     9/10/2014
Hundreds Of Girls Struck With Mystery Illness; Possibly Linked To Merck & Co.'s Gardasil     8/29/2014
U.S. Panel Says Seniors Should Get Pfizer Inc.'s Prevnar 13     8/14/2014
Aduro Biotech Receives Breakthrough Therapy Designation From FDA For Innovative Pancreatic Cancer Combination Immunotherapy     7/23/2014
Sanofi Pasteur Dengue Vaccine Promising But Questions Remain     7/11/2014
GlaxoSmithKline Has 30 Days To Clean Up Plant     7/8/2014

Featured Stories
Do-It-Yourself Flu Vaccine? Study Shows It Works, U.S. Military Vaccine Agency Reveals     10/9/2014
Intestinal Bacteria May Boost Flu Shot's Effects, Emory University Study     9/18/2014
Robert Kennedy's Dangerous Anti-Vaccine Activism     7/22/2014
A Vaccination To Prevent Heart Attacks? Harvard Stem Cell Institute Study     6/11/2014
Vaccine Combo Doubles Seizure Risk In Babies, University of Calgary Study     6/10/2014
Zero Link Between Autism And Vaccines, Vaccine Reveals     5/20/2014
Body Odor Changes Following Vaccination, Monell Chemical Senses Center And United States Department Of Agriculture (USDA) Study     4/3/2014
Proteins May Pave Way to Cow Vaccine, University of Florida Study     7/19/2011
Discovery of Natural Antibody Brings a Universal Flu Vaccine a Step Closer, The Scripps Research Institute Study     7/11/2011
Leeds University Scientists Develop New Approach For Cancer Vaccine     6/21/2011
Drugmakers Including Novartis AG Gear Up to Copy Biotech Drugs in U.S.     5/12/2011
Nasal Spray Vaccine Could Spell the End of the Flu Jab, Albany Medical College Experts Say     4/12/2011
Vaccine Could Cure Cat Allergies, McMaster University Study Suggests     4/6/2011
Promising Target for AIDS Vaccine, Dana-Farber Cancer Institute Study Reveals     4/1/2011
Dual Vaccine Strategy Protects Against Avian Flu, Saint Louis University School of Medicine Finds     2/11/2011

More News
Protein Sciences Corporation Release: Flublok® Influenza Vaccine Now Approved For Adults Ages 18 And Older     10/30/2014
FDA Grants Fast Track Designation To Novavax, Inc. (NVAX)' H7N9 Influenza Virus-Like Particle Vaccine Candidate Adjuvanted With Matrix-M™     10/30/2014
The National Meningitis Association Applauds FDA Approval Of First Serogroup B Meningococcal Disease Vaccine     10/30/2014
Contract Research Organization WCCT Global Announces Involvement In H1N1 Oral Vaccine Development     10/28/2014
BioNet Appoints New COO And Accelerates The Development Of New Recombinant Pertussis Vaccine     10/28/2014
Novavax, Inc. (NVAX) Presents RSV F Protein Nanoparticle Vaccine Clinical Data At The 8th Vaccine & ISV Congress In Philadelphia On Sunday, October 26     10/27/2014
FDA Accepts For Review A Biologics License Application For Merck & Co. (MRK) And Sanofi Pasteur (SASY.PA)’s Investigational Pediatric Hexavalent Vaccine     10/20/2014
Novavax, Inc. (NVAX) Study Published in Vaccine: RSV F-Protein Nanoparticle Vaccine Induces Antigenic Site II Antibodies     10/15/2014
Novavax, Inc. (NVAX) Initiates Phase 2 Clinical Trial Of RSV Vaccine In Elderly Subjects     10/14/2014
EU-Funded Consortium Led By immatics biotechnologies GmbH And BioNTech To Advance A Novel Class Of Fully Personalized Therapeutic Cancer Vaccines Into Clinical Trials For Brain Cancer     10/14/2014
Vaxart, Inc.’s Tablet Vaccine For H1N1 Influenza Generates Protective Immunity Equivalent To Injectable In Phase I Clinical Study     10/14/2014
SELLAS Life Sciences Group Selects PPD, Inc. (PPDI) As Its Strategic CRO Partner To Advance Zolpidem And WT1 Cancer Vaccine     10/14/2014
China's BravoVax In-Licenses Rotavirus Vaccine For Infants     10/14/2014
Public Health Agency of Canada Release: Canadian Ebola Vaccine Trials Begin     10/13/2014
Pfenex Inc. (PFNX) And PATH Partner On Vaccines     10/10/2014

//-->